What is the recommended management for a patient with normal left ventricular systolic function, trace mitral and tricuspid regurgitation, and a left ventricular ejection fraction (LVEF) of 52%?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Trace Mitral and Tricuspid Regurgitation with Normal Left Ventricular Function

No specific treatment is required for trace mitral and tricuspid regurgitation in a patient with normal left ventricular systolic function (LVEF 52%) and normal chamber sizes. 1

Assessment of Current Cardiac Status

The echocardiographic findings indicate:

  • Normal left ventricular systolic function (LVEF 52%)
  • Global Longitudinal Strain of -14.6%
  • Normal left ventricular filling pattern
  • Normal right ventricular size and function
  • Normal left and right atrial size and function
  • Trace mitral regurgitation
  • Trace tricuspid regurgitation

Management Approach

Monitoring and Follow-up

  • Clinical evaluation every 1-2 years 1
  • Repeat echocardiography every 2-3 years if the patient remains stable 1
  • Earlier reassessment if symptoms develop

Medical Management

  • No specific medical therapy is indicated for trace mitral or tricuspid regurgitation when ventricular function is normal 1
  • Vasodilator therapy is not indicated for normotensive asymptomatic patients with trace to mild mitral regurgitation and normal left ventricular function 1

Decision Algorithm for Management

  1. Assess severity of regurgitation

    • Trace mitral and tricuspid regurgitation are considered physiologic and benign
    • Mild mitral regurgitation is defined as jet width <25% of left ventricular outflow tract, vena contracta <0.3 cm, regurgitant volume <30 mL/beat, regurgitant fraction <30%, and effective regurgitant orifice <0.10 cm² 1
  2. Evaluate ventricular function

    • LVEF is 52%, which is within normal range
    • According to guidelines, intervention is only considered when LVEF drops below 60% in severe mitral regurgitation 2
    • Current LVEF does not warrant intervention
  3. Monitor for progression

    • Regular clinical follow-up to detect any symptoms
    • Periodic echocardiography to assess for progression of regurgitation

When to Consider Intervention

Surgical intervention would only be considered if:

  • Regurgitation progresses to severe
  • Patient develops symptoms
  • Left ventricular dysfunction develops (LVEF ≤60% or LV end-systolic dimension ≥40 mm) 2
  • Left ventricular dilation occurs (end-systolic dimension approaching 40 mm) 2

Important Considerations

Potential Pitfalls

  • Overlooking progression of regurgitation that may occur over time
  • Failing to recognize early signs of left ventricular dysfunction, which may occur before LVEF falls below normal range
  • Missing symptoms that may be subtle or attributed to other causes

Prognosis

  • The prognosis for trace mitral and tricuspid regurgitation with preserved left ventricular function is excellent 1
  • Most patients remain stable for many years
  • Progression to severe regurgitation is uncommon in the absence of other cardiac conditions 1

Preventive Measures

  • Maintain overall heart health through:
    • Control of blood pressure
    • Healthy weight maintenance
    • Regular physical activity
    • Avoidance of smoking
    • Management of cholesterol levels 1

In conclusion, trace mitral and tricuspid regurgitation with normal left ventricular function requires only periodic monitoring without specific medical or surgical intervention.

References

Guideline

Management of Mild Mitral and Tricuspid Regurgitation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the treatment plan for a patient with mild mitral and tricuspid regurgitation, normal Left Ventricle (LV) cavity size, normal wall thickness, and normal systolic function with a Left Ventricular Ejection Fraction (LVEF) of 58%?
What is the recommended management for a patient with a left ventricular ejection fraction (LVEF) of 50-55%, mild left atrial dilation, moderate mitral annular calcification, and trace mitral and tricuspid regurgitation?
What is the recommended management approach for a patient with normal systolic function, mild concentric left ventricular hypertrophy, elevated right ventricular systolic pressure, and mild to moderate mitral and tricuspid regurgitation?
What is the management plan for a patient with normal left ventricular systolic function, trace mitral and tricuspid regurgitation, and normal right ventricular function?
What is the management plan for a patient with mild concentric left ventricular hypertrophy (LVH), Grade I diastolic dysfunction, and trace mitral and tricuspid regurgitation?
What neonatal complication is vacuum-assisted vaginal birth most closely associated with: subchorionic hemorrhage, subgaleal hemorrhage, hypobilirubinemia, or hypoglycemia?
What is the time to onset of action for alprazolam (Xanax) vs clonazepam (Klonopin) vs lorazepam (Ativan)?
Which of the following statements about fetal fibronectin (FFN) testing is correct: it is a better predictor of preterm labor than cervical length measured by ultrasound (US), the results are valid for 3 days, it has a high negative predictive value, or it may only be done in tertiary care centers?
What is the difference in time to onset of action between alprazolam (Xanax), clonazepam (Klonopin), and lorazepam (Ativan)?
What is the recommended dosing adjustment for Eliquis (apixaban) in a patient with a history of Deep Vein Thrombosis (DVT) initiating high-dose steroids?
What is the progression and natural history of Aortic (Aortic Valve) stenosis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.